Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Oct;72(4):1047–1053. doi: 10.1038/bjc.1995.460

Trends of skin cancer in the Canton of Vaud, 1976-92.

F Levi 1, S Franceschi 1, V C Te 1, L Randimbison 1, C La Vecchia 1
PMCID: PMC2034057  PMID: 7547221

Abstract

Trends in incidence and mortality for basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and cutaneous malignant melanoma (CMM) for the period 1976-92 were analysed using data from the Cancer Registry of the Swiss Canton of Vaud. Among the 12,473 cases registered, 63% were basal cell carcinomas, 25% squamous cell cancers, 9% cutaneous malignant melanomas and 3% other miscellaneous histological types. Age-standardised incidence rates increased substantially for all histological types considered, from 44% increase for BCC in males to a more than 3-fold increase for SCC in females, with only signs of a levelling off in 1991-92, following a peak of incidence rates in 1986-90. From 1976-80 to 1991-92 CMM incidence increased by approximately 80% in both sexes. In 1991-92, age-standardised (world) incidence rates per 100,000 were 69.3 for basal cell, 29.1 for squamous cell cancers and 11.5 for melanomas in males, and, respectively, 62.2, 18.0 and 12.3 in females. With respect to mortality, in males rates increased for both non-melanocytic cancer (> 40%) and CMM (> 53%) whereas in females CMM, BCC and SCC rates remained approximately stable over the calendar periods examined. In 1991-92, age-standardised mortality rates per 100,000 were 2.6 for melanoma and 0.7 for other skin cancers in males, and, respectively, 1.6 and 0.2 in females. Upward trends in incidence were also present, and relatively homogeneous across, various age groups examined. However, SCC and CMM levelled off over the last period, and some decline was apparent in males below age 45. Separate analysis by anatomical site showed substantial increases in the head and neck for SCC and BCC, and in the trunk for CMM. In 1991-92, middle-aged women had almost equalled male incidence rates of BCC and SCC. A female excess of CMM incidence seemed to have disappeared since 1981-86. The increase in skin cancer incidence thus continued in this population up to the late 1980s, with a plateau only after 1990.

Full text

PDF
1051

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B. K. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol. 1988 Aug;14(8):835–849. doi: 10.1111/j.1524-4725.1988.tb03588.x. [DOI] [PubMed] [Google Scholar]
  2. Brown L., Palmer P. H. Melanoma incidence in Tauranga 1980-9. N Z Med J. 1991 Mar 27;104(908):109–111. [PubMed] [Google Scholar]
  3. Bulliard J. L., Raymond L., Levi F., Schuler G., Enderlin F., Pellaux S., Torhorst J. Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique. 1992;40(6):431–438. [PubMed] [Google Scholar]
  4. Burton R. C., Armstrong B. K. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res. 1994 Apr;4(2):107–113. doi: 10.1097/00008390-199404000-00005. [DOI] [PubMed] [Google Scholar]
  5. Burton R. C., Coates M. S., Hersey P., Roberts G., Chetty M. P., Chen S., Hayes M. H., Howe C. G., Armstrong B. K. An analysis of a melanoma epidemic. Int J Cancer. 1993 Nov 11;55(5):765–770. doi: 10.1002/ijc.2910550512. [DOI] [PubMed] [Google Scholar]
  6. Coebergh J. W., Neumann H. A., Vrints L. W., van der Heijden L., Meijer W. J., Verhagen-Teulings M. T. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol. 1991 Oct;125(4):353–359. doi: 10.1111/j.1365-2133.1991.tb14171.x. [DOI] [PubMed] [Google Scholar]
  7. Cooke K., McNoe B., Hursthouse M., Taylor R. Primary malignant melanoma of skin in four regions of New Zealand. N Z Med J. 1992 Aug 12;105(939):303–306. [PubMed] [Google Scholar]
  8. Dennis L. K., White E., Lee J. A. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control. 1993 Mar;4(2):93–100. doi: 10.1007/BF00053149. [DOI] [PubMed] [Google Scholar]
  9. Fears T. R., Scotto J. Changes in skin cancer morbidity between 1971-72 and 1977-78. J Natl Cancer Inst. 1982 Aug;69(2):365–370. [PubMed] [Google Scholar]
  10. Franceschi S., Bidoli E., Prati S., Fascioli S., La Vecchia C. Mortality from skin melanoma in Italy and Friuli-Venezia Giulia region, 1970-1989. Tumori. 1994 Aug 31;80(4):251–256. doi: 10.1177/030089169408000401. [DOI] [PubMed] [Google Scholar]
  11. Franceschi S., La Vecchia C., Lucchini F., Cristofolini M. The epidemiology of cutaneous malignant melanoma: aetiology and European data. Eur J Cancer Prev. 1991 Oct;1(1):9–22. doi: 10.1097/00008469-199110000-00003. [DOI] [PubMed] [Google Scholar]
  12. Franceschi S., La Vecchia C., Negri E., Levi F. Increases in mortality from cutaneous melanoma in southern Europe. Int J Cancer. 1992 Apr 22;51(1):160–162. doi: 10.1002/ijc.2910510128. [DOI] [PubMed] [Google Scholar]
  13. Gallagher R. P., Ma B., McLean D. I., Yang C. P., Ho V., Carruthers J. A., Warshawski L. M. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):413–421. doi: 10.1016/0190-9622(90)70234-9. [DOI] [PubMed] [Google Scholar]
  14. Giles G. G., Marks R., Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988 Jan 2;296(6614):13–17. doi: 10.1136/bmj.296.6614.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Glass A. G., Hoover R. N. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989 Oct 20;262(15):2097–2100. [PubMed] [Google Scholar]
  16. Harvey I., Shalom D., Marks R. M., Frankel S. J. Non-melanoma skin cancer. BMJ. 1989 Nov 4;299(6708):1118–1120. doi: 10.1136/bmj.299.6708.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jones M. E., Shugg D., Dwyer T., Young B., Bonett A. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust. 1992 Sep 21;157(6):373–378. [PubMed] [Google Scholar]
  18. Kaldor J., Shugg D., Young B., Dwyer T., Wang Y. G. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer. 1993 Apr 1;53(6):886–891. doi: 10.1002/ijc.2910530603. [DOI] [PubMed] [Google Scholar]
  19. Koh H. K., Geller A. C., Miller D. R., Lew R. A. Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol. 1993 Apr;28(4):645–647. doi: 10.1016/s0190-9622(08)81786-0. [DOI] [PubMed] [Google Scholar]
  20. Kricker A., Armstrong B. K., English D. R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994 Jul;5(4):367–392. doi: 10.1007/BF01804988. [DOI] [PubMed] [Google Scholar]
  21. Levi F. G., Chapallaz S. Les cancers de la peau dans le canton de Vaud. Etude descriptive des cas enregistrés de 1974 à 1978 par le registre vaudois des tumeurs. Schweiz Rundsch Med Prax. 1981 Jun 16;70(25):1120–1130. [PubMed] [Google Scholar]
  22. Levi F., La Vecchia C., Te V. C., Mezzanotte G. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer. 1988 Dec 15;42(6):811–816. doi: 10.1002/ijc.2910420601. [DOI] [PubMed] [Google Scholar]
  23. MacKie R., Hunter J. A., Aitchison T. C., Hole D., Mclaren K., Rankin R., Blessing K., Evans A. T., Hutcheon A. W., Jones D. H. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. doi: 10.1016/0140-6736(92)91539-k. [DOI] [PubMed] [Google Scholar]
  24. MacLennan R., Green A. C., McLeod G. R., Martin N. G. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992 Sep 16;84(18):1427–1432. doi: 10.1093/jnci/84.18.1427. [DOI] [PubMed] [Google Scholar]
  25. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer. 1991 Jan 2;47(1):12–19. doi: 10.1002/ijc.2910470104. [DOI] [PubMed] [Google Scholar]
  26. Marks R., Staples M., Giles G. G. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer. 1993 Feb 20;53(4):585–590. doi: 10.1002/ijc.2910530410. [DOI] [PubMed] [Google Scholar]
  27. Osterlind A., Engholm G., Jensen O. M. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site. APMIS. 1988 Nov;96(11):953–963. doi: 10.1111/j.1699-0463.1988.tb00968.x. [DOI] [PubMed] [Google Scholar]
  28. Percy C., Stanek E., 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981 Mar;71(3):242–250. doi: 10.2105/ajph.71.3.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pollán M., López-Abente G. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986. Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):545–550. [PubMed] [Google Scholar]
  30. Roush G. C., McKay L., Holford T. R. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer. 1992 Apr 1;69(7):1714–1720. doi: 10.1002/1097-0142(19920401)69:7<1714::aid-cncr2820690712>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES